2024년에 11억 달러로 추정되는 세계의 생검 가이던스 시스템 시장은 2024-2030년의 분석 기간에 CAGR 4.7%로 성장하며, 2030년에는 14억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 정위 유도 생검은 CAGR 5.5%를 기록하며, 분석 기간 종료시에는 8억 2,520만 달러에 달할 것으로 예측됩니다. 초음파 유도 생검 부문의 성장률은 분석 기간 중 CAGR 4.2%로 추정됩니다.
미국 시장은 추정 2억 9,490만 달러, 중국은 CAGR 8.7%로 성장 예측
미국의 생검 가이던스 시스템 시장은 2024년에 2억 9,490만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2024-2030년의 분석 기간에 CAGR 8.7%로 추이하며, 2030년에는 예측 시장 규모 3억 10만 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.9%와 3.7%로 예측됩니다. 유럽에서는 독일이 CAGR 2.8%로 성장할 것으로 예측됩니다.
세계의 생검 가이던스 시스템 시장 - 주요 동향과 촉진요인 정리
생검 유도 시스템이 현대 진단에 필수적인 이유는 무엇인가?
생검 가이던스 시스템은 현대 의료 진단에서 필수적인 툴이 되어 더 높은 정확성, 효율성, 조직 샘플링의 저침습성을 실현하고 있습니다. 이 시스템들은 초음파, MRI, CT 스캔, 로봇 보조 내비게이션 등 첨단 영상 기술을 사용하여 바늘 생검을 정확하게 유도합니다. 전 세계에서 암 및 기타 만성질환에 대한 부담이 증가함에 따라 고정밀 생검 기술에 대한 수요가 급증하고 있으며, 생검 가이던스 시스템은 조기 발견, 치료 계획 및 질병 모니터링에 있으며, 매우 중요한 역할을 하고 있습니다.
생검 유도 시스템은 환자의 불편함을 줄이고, 합병증 발생률을 낮추며, 시술 효율을 높이기 때문에 저침습적 시술로의 전환은 생검 유도 시스템의 채택을 더욱 촉진하고 있습니다. 또한 이러한 시스템에서 인공지능(AI)과 실시간 이미지의 통합은 진단의 정확성과 의사의 신뢰성을 향상시키고 있습니다. 맞춤의료와 표적치료가 강조되고 있는 가운데, 생검 가이던스 시스템은 분자 및 유전자 프로파일링에 필요한 고품질 조직 샘플을 제공하는 데 중요한 역할을 하고 있습니다. 의료 서비스 프로바이더가 조기 발견과 정밀진단을 우선시하는 가운데, 생검 안내 시스템 시장은 향후 수년간 크게 확대될 것으로 예측됩니다.
기술 발전은 생검 안내 시스템을 어떻게 개선하고 있는가?
영상 처리, 로봇 공학 및 AI의 혁신은 생검 안내 시스템을 보다 정확하고 효율적이며 사용자 친화적으로 변화시키고 있습니다. 가장 중요한 발전 중 하나는 AI를 활용한 이미지 인식과 실시간 분석의 통합으로, 방사선과 의사와 외과 의사가 보다 높은 정확도로 최적의 생검 부위를 식별할 수 있게 되었습니다는 점입니다. AI가 탑재된 생검 시스템은 이미지 데이터를 실시간으로 분석하여 바늘 배치에 대한 자동 추천을 제공하여 위음성의 위험을 줄일 수 있습니다. 또한 3D 이미지와 증강현실(AR) 오버레이를 통해 시각화 기능이 강화되어 임상의가 복잡한 해부학적 구조를 그 어느 때보다 명확하게 탐색할 수 있게 되었습니다.
생검 유도 기술의 또 다른 혁신은 우수한 바늘 제어, 안정성 및 자동화를 제공하는 로봇 보조 생검 시스템의 개발입니다. 이러한 시스템은 인위적인 실수를 최소화하고, 작은 병변이나 도달하기 어려운 병변을 보다 정확하게 표적화할 수 있습니다. 또한 엘라스토그래피와 조영 초음파의 발전으로 연부조직의 감별이 향상되어 조직이 밀집된 환경에서도 악성 종양을 더 잘 감지할 수 있게 되었습니다. 또한 무선으로 휴대할 수 있는 생검 안내 시스템은 외래 환자나 원격의료시설에서 사용할 수 있는 유연성을 제공하여 인기를 끌고 있습니다. 이러한 기술 혁신이 계속 발전함에 따라 생검 안내 시스템은 점점 더 효율적이고 정확해져 다양한 의료 서비스 프로바이더가 이용할 수 있게 되었습니다.
생검 가이던스 시스템의 성장을 가속하는 시장 동향은?
암 및 기타 만성질환의 전 세계 발병률 증가는 생검 가이던스 시스템 시장을 촉진하는 가장 중요한 동향 중 하나입니다. 전 세계에서 암 발병률이 증가함에 따라 조기 및 정확한 진단이 의료 서비스 프로바이더의 주요 관심사로 떠오르면서 첨단 생검 유도 기술을 채택하는 추세입니다. 또한 영상 유도를 통한 최소침습 수술의 인기가 높아짐에 따라 환자의 불편함을 최소화하면서 높은 정확도를 제공하는 시스템에 대한 수요가 증가하고 있습니다. 그 결과, MRI 유도하 및 초음파 유도 생검 시스템은 종양학, 유방 영상 진단, 중재적 방사선학 분야에서 널리 사용되고 있습니다.
시장을 형성하는 또 다른 주요 동향은 AI 기반 헬스케어 솔루션의 확대입니다. AI를 통한 생검 지침은 워크플로우의 효율성을 개선하고, 생검 처리 시간을 단축하며, 작업자에 대한 의존도를 최소화함으로써 보다 많은 의료진이 이러한 시스템을 쉽게 이용할 수 있도록 돕습니다. 또한 액체생검과 분자진단의 부상은 전통적인 조직 생검을 보완하고 있으며, 영상 진단과 바이오마커 검출을 통합한 하이브리드 생검 가이던스 솔루션의 개발로 이어지고 있습니다. 원격의료 및 원격 진단의 채택이 증가함에 따라 복잡한 사례에 대한 실시간 진료 및 원격 전문가 가이드를 가능하게 하는 휴대용 클라우드 연결이 가능한 생검 안내 시스템에 대한 수요가 증가하고 있습니다.
생검 안내 시스템 시장 전망를 형성하는 주요 성장 동력은 무엇인가?
생검 유도 시스템 시장의 성장은 암 발병률 증가, 영상 기술의 발전, 정밀의료에 대한 투자 증가 등 몇 가지 중요한 요인에 의해 이루어지고 있습니다. 주요 성장 요인 중 하나는 암의 조기 발견 및 진단에 대한 중요성이 강조되면서 검진 프로그램 및 진단 절차가 증가하고 있다는 점입니다. 전 세계 정부와 의료 기관은 암 인식 제고 구상을 시행하고 있으며, 진단 정확도를 향상시키기 위해 첨단 생검 지침 시스템의 채택을 더욱 촉진하고 있습니다.
시장을 형성하는 또 다른 중요한 촉진요인은 생검 절차에 AI와 로봇 공학의 통합입니다. AI 기반 의사결정 지원 툴은 더 빠르고 정확한 진단을 가능하게 하고, 로봇 지원 시스템은 생검 정확도를 향상시키고, 시술 관련 합병증을 감소시키고 있습니다. 또한 외래 환자 및 외래 진료 서비스에 대한 수요가 증가함에 따라 작고 휴대 가능하며 비용 효율적인 생검 안내 시스템의 필요성이 증가하고 있습니다. 의료진이 환자의 불편함을 최소화하면서 진단 효율성을 높이기 위해 노력하는 가운데, 첨단 생검 가이던스 시스템의 도입이 가속화되면서 정밀의료와 암 진단의 미래에서 중요한 툴로 자리매김할 것으로 예측됩니다.
부문
제품 유형(정위 유도 생검, 초음파 유도 생검, MRI 유도 생검), 용도(뇌생검 용도, 유방 생검 용도, 기타 용도), 최종 용도(병원 최종 용도, 전문 클리닉 최종 용도, 진단 센터 최종 용도, 연구·학술기관 최종 용도)
조사 대상 기업의 예
Argon Medical Devices, Inc.
Becton, Dickinson and Company(BD)
Boston Scientific Corporation
Cardinal Health, Inc.
Cook Medical, LLC
Hologic, Inc.
INRAD, Inc.
Mammotome
PAJUNK(R) GmbH
Planmed Oy
Siemens Healthineers AG
Trivitron Healthcare
AI 통합
Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.
Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.
목차
제1장 조사 방법
제2장 개요
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트
기타 중동
아프리카
제4장 경쟁
KSA
영문 목차
영문목차
Global Biopsy Guidance Systems Market to Reach US$1.4 Billion by 2030
The global market for Biopsy Guidance Systems estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Stereotactic Guided Biopsy, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$825.2 Million by the end of the analysis period. Growth in the Ultrasound Guided Biopsy segment is estimated at 4.2% CAGR over the analysis period.
The U.S. Market is Estimated at US$294.9 Million While China is Forecast to Grow at 8.7% CAGR
The Biopsy Guidance Systems market in the U.S. is estimated at US$294.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$300.1 Million by the year 2030 trailing a CAGR of 8.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.
Global Biopsy Guidance Systems Market - Key Trends & Drivers Summarized
Why Are Biopsy Guidance Systems Becoming Essential in Modern Diagnostics?
Biopsy guidance systems have become an indispensable tool in modern medical diagnostics, enabling greater accuracy, efficiency, and minimally invasive procedures for tissue sampling. These systems use advanced imaging technologies, including ultrasound, MRI, CT scans, and robotic-assisted navigation, to guide needle biopsies with precision. As the global burden of cancer and other chronic diseases continues to rise, the demand for highly accurate biopsy techniques has surged, making biopsy guidance systems crucial for early detection, treatment planning, and disease monitoring.
The shift toward minimally invasive procedures is further driving the adoption of biopsy guidance systems, as they reduce patient discomfort, lower complication rates, and enhance procedural efficiency. Additionally, the integration of artificial intelligence (AI) and real-time imaging in these systems is improving diagnostic accuracy and physician confidence. With the growing emphasis on personalized medicine and targeted therapies, biopsy guidance systems are playing a critical role in providing high-quality tissue samples necessary for molecular and genetic profiling. As healthcare providers prioritize early detection and precision diagnostics, the market for biopsy guidance systems is expected to expand significantly in the coming years.
How Are Technological Advancements Improving Biopsy Guidance Systems?
Technological innovations in imaging, robotics, and AI are transforming biopsy guidance systems, making them more precise, efficient, and user-friendly. One of the most significant advancements is the integration of AI-powered image recognition and real-time analytics, which help radiologists and surgeons identify optimal biopsy sites with greater accuracy. AI-enhanced biopsy systems can analyze imaging data in real time, providing automated recommendations for needle placement and reducing the risk of false-negative results. Additionally, 3D imaging and augmented reality (AR) overlays are enhancing visualization capabilities, allowing clinicians to navigate complex anatomical structures with unprecedented clarity.
Another breakthrough in biopsy guidance technology is the development of robotic-assisted biopsy systems, which provide superior needle control, stability, and automation. These systems minimize human error and allow for more precise targeting of small or difficult-to-reach lesions. Additionally, advancements in elastography and contrast-enhanced ultrasound are improving soft tissue differentiation, enabling better detection of malignant tumors in dense tissue environments. Wireless and portable biopsy guidance systems are also gaining traction, offering greater flexibility for use in outpatient settings and remote healthcare facilities. As these technological innovations continue to evolve, biopsy guidance systems are becoming increasingly efficient, accurate, and accessible to a broader range of healthcare providers.
Which Market Trends Are Driving the Growth of Biopsy Guidance Systems?
The increasing global incidence of cancer and other chronic diseases is one of the most significant trends driving the biopsy guidance systems market. With cancer rates rising worldwide, early and accurate diagnosis has become a primary focus for healthcare providers, leading to greater adoption of advanced biopsy guidance technologies. Additionally, the growing popularity of image-guided minimally invasive procedures is accelerating demand for systems that offer high precision with minimal patient discomfort. As a result, MRI-guided and ultrasound-guided biopsy systems are gaining widespread acceptance in oncology, breast imaging, and interventional radiology.
Another key trend shaping the market is the expansion of AI-driven healthcare solutions. AI-assisted biopsy guidance is improving workflow efficiency, reducing biopsy procedure times, and minimizing operator dependency, making these systems more accessible to a wider range of medical professionals. Furthermore, the rise of liquid biopsy and molecular diagnostics is complementing traditional tissue biopsies, leading to the development of hybrid biopsy guidance solutions that integrate imaging with biomarker detection. The increasing adoption of telemedicine and remote diagnostics is also fueling demand for portable and cloud-connected biopsy guidance systems, enabling real-time consultation and remote expert guidance for complex cases.
What Are the Key Growth Drivers Shaping the Future of the Biopsy Guidance Systems Market?
The growth in the biopsy guidance systems market is driven by several key factors, including rising cancer prevalence, advancements in imaging technology, and increasing investments in precision medicine. One of the primary growth drivers is the growing emphasis on early cancer detection and diagnosis, which has led to increased screening programs and diagnostic procedures. Governments and healthcare organizations worldwide are implementing cancer awareness initiatives, further driving the adoption of advanced biopsy guidance systems to improve diagnostic accuracy.
Another crucial driver shaping the market is the integration of AI and robotics in biopsy procedures. AI-driven decision support tools are enabling faster and more accurate diagnoses, while robotic-assisted systems are improving biopsy precision and reducing procedure-related complications. Additionally, the growing demand for outpatient and ambulatory care services is driving the need for compact, portable, and cost-effective biopsy guidance systems. As healthcare providers seek to enhance diagnostic efficiency while minimizing patient discomfort, the adoption of advanced biopsy guidance systems is expected to accelerate, positioning them as a critical tool in the future of precision medicine and cancer diagnostics.
SCOPE OF STUDY:
The report analyzes the Biopsy Guidance Systems market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product Type (Stereotactic Guided Biopsy, Ultrasound Guided Biopsy, MRI Guided Biopsy); Application (Brain Biopsy Application, Breast Biopsy Application, Other Applications); End-Use (Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use, Research and Academic Institutes End-Use)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 39 Featured) -
Argon Medical Devices, Inc.
Becton, Dickinson and Company (BD)
Boston Scientific Corporation
Cardinal Health, Inc.
Cook Medical, LLC
Hologic, Inc.
INRAD, Inc.
Mammotome
PAJUNK(R) GmbH
Planmed Oy
Siemens Healthineers AG
Trivitron Healthcare
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Biopsy Guidance Systems - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Global Burden of Cancer and Chronic Diseases Throws the Spotlight on Biopsy Guidance Systems for Accurate Diagnostics
Surge in Demand for Minimally Invasive Procedures Drives Adoption of Image-Guided Biopsy Technologies
Technological Advancements in Imaging Modalities Strengthen the Business Case for Real-Time Biopsy Guidance Systems
Shift Toward Early and Precision Diagnosis Expands Addressable Market Opportunity for Targeted Biopsy Devices
Integration of Ultrasound, CT, MRI, and Fusion Imaging Enhances Accuracy and Outcomes of Biopsy Procedures
Increasing Preference for Outpatient and Ambulatory Biopsy Settings Fuels Demand for Portable and User-Friendly Guidance Systems
Growth in Interventional Radiology and Image-Guided Oncology Spurs Wider Adoption of Navigation and Targeting Technologies
AI-Powered Imaging and Software-Driven Needle Guidance Systems Propel Innovation in Biopsy Procedures
Rising Demand for Organ-Specific and Site-Specific Biopsy Solutions Drives Market Segmentation and Customization
Improved Patient Comfort and Procedural Efficiency Strengthen the Shift from Manual to Automated Biopsy Guidance Systems
Advancements in Robotics and 3D Navigation Technologies Enhance Precision and Reduce Human Error in Biopsy Procedures
Increasing Adoption of Real-Time Tissue Characterization and Elastography Supports Intelligent Biopsy Targeting
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Biopsy Guidance Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 3: World 6-Year Perspective for Biopsy Guidance Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Stereotactic Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 5: World 6-Year Perspective for Stereotactic Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 6: World Recent Past, Current & Future Analysis for Ultrasound Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 7: World 6-Year Perspective for Ultrasound Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for MRI Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 9: World 6-Year Perspective for MRI Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Research and Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 11: World 6-Year Perspective for Research and Academic Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 12: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 13: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 15: World 6-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 17: World 6-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 18: World Recent Past, Current & Future Analysis for Brain Biopsy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 19: World 6-Year Perspective for Brain Biopsy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Breast Biopsy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 21: World 6-Year Perspective for Breast Biopsy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 23: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 24: USA Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 25: USA 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 27: USA 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 28: USA Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 29: USA 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
CANADA
TABLE 30: Canada Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 31: Canada 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 32: Canada Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 33: Canada 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 34: Canada Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 35: Canada 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
JAPAN
Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 36: Japan Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 37: Japan 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 38: Japan Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 39: Japan 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 40: Japan Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 41: Japan 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
CHINA
Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 42: China Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 43: China 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 44: China Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 45: China 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 46: China Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 47: China 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
EUROPE
Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 48: Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 49: Europe 6-Year Perspective for Biopsy Guidance Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2025 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 51: Europe 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 52: Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 53: Europe 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 54: Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 55: Europe 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
FRANCE
Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 56: France Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 57: France 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 58: France Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 59: France 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 60: France Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 61: France 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
GERMANY
Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 62: Germany Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 63: Germany 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 64: Germany Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 65: Germany 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 66: Germany Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 67: Germany 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
ITALY
TABLE 68: Italy Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 69: Italy 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 70: Italy Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 71: Italy 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 72: Italy Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 73: Italy 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
UNITED KINGDOM
Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 74: UK Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 75: UK 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 76: UK Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 77: UK 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 78: UK Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 79: UK 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
SPAIN
TABLE 80: Spain Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 81: Spain 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 82: Spain Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 83: Spain 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 84: Spain Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 85: Spain 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
RUSSIA
TABLE 86: Russia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 87: Russia 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 88: Russia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 89: Russia 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 90: Russia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 91: Russia 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
REST OF EUROPE
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 93: Rest of Europe 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 95: Rest of Europe 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 96: Rest of Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 97: Rest of Europe 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
ASIA-PACIFIC
Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 99: Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2025 & 2030
TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 101: Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 102: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 103: Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 105: Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
AUSTRALIA
Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 106: Australia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 107: Australia 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 108: Australia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 109: Australia 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 110: Australia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 111: Australia 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
INDIA
Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 112: India Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 113: India 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 114: India Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 115: India 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 116: India Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 117: India 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
SOUTH KOREA
TABLE 118: South Korea Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 119: South Korea 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 120: South Korea Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 121: South Korea 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 122: South Korea Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 123: South Korea 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 124: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 125: Rest of Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 126: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 127: Rest of Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 129: Rest of Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
LATIN AMERICA
Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 130: Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 131: Latin America 6-Year Perspective for Biopsy Guidance Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2025 & 2030
TABLE 132: Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 133: Latin America 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 134: Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 135: Latin America 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 136: Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 137: Latin America 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
ARGENTINA
TABLE 138: Argentina Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 139: Argentina 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 140: Argentina Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 141: Argentina 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 142: Argentina Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 143: Argentina 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
BRAZIL
TABLE 144: Brazil Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 145: Brazil 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 146: Brazil Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 147: Brazil 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 148: Brazil Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 149: Brazil 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
MEXICO
TABLE 150: Mexico Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 151: Mexico 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 152: Mexico Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 153: Mexico 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 154: Mexico Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 155: Mexico 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
REST OF LATIN AMERICA
TABLE 156: Rest of Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 157: Rest of Latin America 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 159: Rest of Latin America 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 160: Rest of Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 161: Rest of Latin America 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
MIDDLE EAST
Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 162: Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 163: Middle East 6-Year Perspective for Biopsy Guidance Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2025 & 2030
TABLE 164: Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 165: Middle East 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 166: Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 167: Middle East 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 168: Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 169: Middle East 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
IRAN
TABLE 170: Iran Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 171: Iran 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 172: Iran Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 173: Iran 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 174: Iran Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 175: Iran 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
ISRAEL
TABLE 176: Israel Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 177: Israel 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 178: Israel Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 179: Israel 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 180: Israel Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 181: Israel 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
SAUDI ARABIA
TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 183: Saudi Arabia 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 184: Saudi Arabia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 185: Saudi Arabia 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 186: Saudi Arabia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 187: Saudi Arabia 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
UNITED ARAB EMIRATES
TABLE 188: UAE Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 189: UAE 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 190: UAE Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 191: UAE 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 192: UAE Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 193: UAE 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
REST OF MIDDLE EAST
TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 195: Rest of Middle East 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 196: Rest of Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 197: Rest of Middle East 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 198: Rest of Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 199: Rest of Middle East 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
AFRICA
Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 200: Africa Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 201: Africa 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
TABLE 202: Africa Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 203: Africa 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
TABLE 204: Africa Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 205: Africa 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
